Skip to content
ASCENDO BiotechnologyASCENDO Biotechnology
  • About
  • Science
    • sTLT-1
  • Pipeline
    • ASD141
    • NanoCherub®
  • Partnering
  • News
  • Contact

News

Ascendo highlights the limitless potential of the adaptive immune pathway for future cancer immunotherapies at the 2022 International BIO convention
2022-06-30

The theme of this year’s BIO conference 2022 was ‘limit....

21 October 2021,World Vaccine Congress Europe 2021, Barcelona, Spain
2021-10-14

Oral Presentation/A pre-IND versatile nanocomplex forme....

10-14 November 2021, The Society for Immunotherapy of Cancer’s (SITC) 36th (SITC 2021), Washington DC, USA
2021-10-14

Poster Presentation/ASD141, an innate checkpoint inhibi....

  • About
  • ASD141
  • Pipeline
  • Partnering
  • News
  • Contact
Copyright 2023 © ASCENDO BIOTECHNOLOGY INC.
Website design and development by Sciad Communications
  • About
  • Science
    • sTLT-1
  • Pipeline
    • ASD141
    • NanoCherub®
  • Partnering
  • News
  • Contact